Skip to content
The Accidental Order
  • Home
  • Stock Tracking
  • Company Analysis
  • Learn InvestingExpand
    • Investing Basics
    • Fundamental Analysis
    • Technical Analysis
    • Market Data
  • Data
  • About
  • KO|EN
The Accidental Order
  • Screening Methodology for Overlooked Stocks — How 2,765 Companies Became 207
    Learn Investing

    Screening Methodology for Overlooked Stocks — How 2,765 Companies Became 207

    2026-07-182026-08-21

    The full blueprint of The Accidental Order’s six-layer screening funnel: every threshold, every stage-by-stage count as measured on 2026-07-18, and the companies the filter structurally fails to see.

    Read More Screening Methodology for Overlooked Stocks — How 2,765 Companies Became 207Continue

  • Earnings Season Preview — Nine Tracked Companies and What to Watch in July and August
    Company Analysis

    Earnings Season Preview — Nine Tracked Companies and What to Watch in July and August

    2026-07-182026-08-21

    The update hub for The Accidental Order’s nine tracked companies in the 2026 Q2 earnings season: each company’s core scenario, the numbers to check, and the filing calendar from last year’s dates.

    Read More Earnings Season Preview — Nine Tracked Companies and What to Watch in July and AugustContinue

  • SCD (042110): More Cash Than Market Cap — When Does That Money Become the Shareholders’?
    Company Analysis - Electronic Components

    SCD (042110): More Cash Than Market Cap — When Does That Money Become the Shareholders’?

    2026-07-182026-08-21

    SCD holds KRW 73.7bn of cash against a KRW 63.1bn market cap with zero debt, and has raised its dividend three years running. But operating profit has thinned for five straight quarters, to KRW 510m.

    Read More SCD (042110): More Cash Than Market Cap — When Does That Money Become the Shareholders’?Continue

  • Whanin Pharmaceutical (016580): the quiet leader in psychiatric drugs — why profit collapsed, and whether the rebound is real
    Company Analysis - Pharma & Bio

    Whanin Pharmaceutical (016580): the quiet leader in psychiatric drugs — why profit collapsed, and whether the rebound is real

    2026-07-182026-08-21

    Korea’s number one psychiatric drug maker saw its operating margin erode from 17.6% to 5.1% over five years, then posted a sharp rebound in Q1 2026. Two scenarios, with thresholds set in advance.

    Read More Whanin Pharmaceutical (016580): the quiet leader in psychiatric drugs — why profit collapsed, and whether the rebound is realContinue

  • SK Hynix (000660): a 12x rally and the first week of the listing — what to watch
    Company Analysis - Semiconductors

    SK Hynix (000660): a 12x rally and the first week of the listing — what to watch

    2026-07-142026-08-21

    The same method we use on overlooked small caps, applied to Korea’s most heavily covered stock. A core scenario on whether the KRW 40tn raised comes back as profit, plus two watch points checked every quarter.

    Read More SK Hynix (000660): a 12x rally and the first week of the listing — what to watchContinue

  • Technical analysis, from the ground up — a six-part learning roadmap
    Learn Investing

    Technical analysis, from the ground up — a six-part learning roadmap

    2026-07-132026-08-21

    A guide that threads together the six-part technical analysis series: chart basics, price structure, indicators, and verification and reality. It teaches the limits of a signal alongside the signal itself.

    Read More Technical analysis, from the ground up — a six-part learning roadmapContinue

  • Mastering Fundamental Analysis — A 10-Part Learning Roadmap
    Learn Investing

    Mastering Fundamental Analysis — A 10-Part Learning Roadmap

    2026-07-132026-08-21

    A contents page and study guide threading together ten instalments on fundamental analysis, in four stages: statement basics, accounting traps, profitability and valuation, and capital allocation.

    Read More Mastering Fundamental Analysis — A 10-Part Learning RoadmapContinue

  • Overlooked Stocks and Charts — How to Read the Liquidity Trap
    Learn Investing - Technical Analysis

    Overlooked Stocks and Charts — How to Read the Liquidity Trap

    2026-07-132026-08-21

    Why the usual technical signals fail in thinly traded, overlooked stocks, and how the spread, slippage and market impact of thin liquidity distort candles, indicators and exits.

    Read More Overlooked Stocks and Charts — How to Read the Liquidity TrapContinue

  • Backtesting 101: Verify With the Past Without Being Fooled By It
    Learn Investing - Technical Analysis

    Backtesting 101: Verify With the Past Without Being Fooled By It

    2026-07-132026-08-21

    What a backtest is and why dazzling results should not be trusted at face value — overfitting, look-ahead bias, survivorship bias, trading costs and data snooping, plus how to verify honestly.

    Read More Backtesting 101: Verify With the Past Without Being Fooled By ItContinue

  • Audit Reports and the Notes: Can You Trust the Numbers, and What to Watch For
    Fundamental Analysis - Learn Investing

    Audit Reports and the Notes: Can You Trust the Numbers, and What to Watch For

    2026-07-132026-08-21

    An unqualified opinion is a minimum condition, not a guarantee of quality. How to read audit opinions, and how to find going-concern and related-party risk in the notes.

    Read More Audit Reports and the Notes: Can You Trust the Numbers, and What to Watch ForContinue

  • Capital Allocation: Skill Shows in Where the Money Earned Is Spent
    Fundamental Analysis - Learn Investing

    Capital Allocation: Skill Shows in Where the Money Earned Is Spent

    2026-07-132026-08-21

    The five destinations for cash a company earns, and the tests for good and bad allocation, seen through Muhak’s dividend increase and its thick net cash.

    Read More Capital Allocation: Skill Shows in Where the Money Earned Is SpentContinue

Page navigation

Previous PagePrevious 1 2 3 4 5 Next PageNext

Categories

  • Learn Investing
    • Investing Basics
    • Market Data
    • Fundamental Analysis
    • Technical Analysis
  • Company Analysis
    • Consumer Staples
    • Consumer Discretionary
    • Materials & Components
    • Semiconductors
    • Pharma & Bio
    • Electronic Components
    • Auto Parts

Free Newsletter

New analyses and quarterly updates, by email. Nothing else.

The Accidental OrderHome · Stock Tracking · Company Analysis · Learn Investing · Data · About
Company · Contact · Disclaimer · Privacy Policy
© 2026 The Accidental Order Co., Ltd. · contact@accidentalorder.com

Scroll to top
  • Home
  • Stock Tracking
  • Company Analysis
  • Learn Investing
    • Investing Basics
    • Fundamental Analysis
    • Technical Analysis
    • Market Data
  • Data
  • About
  • KO|EN